g.d. searle & co. said 0 the food and drug administration approved the sale of kerlone , a hypertension drug developed by a joint venture between searle and a french concern . searle , a unit of monsanto co. , said 0 the `` beta-blocker '' high-blood-pressure drug kerlone is the first product 0 to reach the market through lorex pharmaceuticals , the u.s. company jointly owned by searle and synthelabo , a french pharmaceutical concern owned by france 's l'oreal s.a .